Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Drops By 22.1%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the recipient of a significant decrease in short interest in October. As of October 15th, there was short interest totalling 196,000 shares, a decrease of 22.1% from the September 30th total of 251,600 shares. Currently, 5.7% of the company’s stock are sold short. Based on an average daily trading volume, of 628,200 shares, the days-to-cover ratio is presently 0.3 days.

China SXT Pharmaceuticals Price Performance

NASDAQ:SXTC traded up $0.02 during trading hours on Tuesday, reaching $0.61. 270,837 shares of the stock were exchanged, compared to its average volume of 777,048. The firm has a 50 day simple moving average of $0.67 and a 200-day simple moving average of $0.94. The company has a current ratio of 1.60, a quick ratio of 1.51 and a debt-to-equity ratio of 0.01. China SXT Pharmaceuticals has a 52 week low of $0.53 and a 52 week high of $6.39.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.